Method and apparatus for determining oversensing in a medical device

• US 7,774,049 B2
• Filed: 05/01/2007
• Issued: 08/10/2010
• Est. Priority Date: 05/01/2007
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Kleckner, Karen J., Krause, Paul G., Ghanem, Raja N., Stadler, Robert W., Zhang, Xusheng
• Primary Examiner(s): Schaetzle; Kennedy J
• Assistant Examiner(s): SARCIONE, JESSICA LYNN
• Application Number:
  US11/742,616
• Publication Number:
  US 20080275518A1
• Time in Patent Office: 1,197 Days
• Field of Search: 607/4, 607/5, 607/9, 607/14, 607/17, 607/25, 607/26, 600/509, 600/510, 600515-519, 600/521
• US Class Current: 600/509
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

A method and apparatus for determining oversensing of cardiac signals that includes a housing containing electronic circuitry, an electrode coupled to the electronic circuitry to sense cardiac signals, and a processor, positioned within the housing, to determine an oversensing characteristic associated with the cardiac signals sensed over a predetermined sensing window, and to identify oversensing in response to the determined oversensing characteristic.

Claims

1. A medical device comprising:

a housing containing electronic circuitry; and

a plurality of electrodes coupled to the electronic circuitry that sense at least one cardiac signal,

wherein the electronic circuitry comprises a processor that;

analyzes the at least one cardiac signal on a beat-to-beat basis,

determines a first characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal on the beat-to-beat basis,

identifies a cardiac event based on the first characteristic of the at least one cardiac signal,

in response to identifying the cardiac event, analyzes the at least one cardiac signal within at least one predetermined sensing window, the at least one predetermined sensing window comprising a predetermined duration of time unrelated to one or more beat-to-beat durations,

determines a second characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal within the at least one predetermined sensing window, and

identifies oversensing based on the second characteristic, wherein the processor transitions the medical device between a first state and a second state when the processor identifies the cardiac event.

2. The medical device of claim 1, wherein the plurality of electrodes sense the at least one cardiac signal from a non-intravenous location.

3. A medical device comprising:

a housing containing electronic circuitry; and

a plurality of electrodes coupled to the electronic circuitry that sense at least one cardiac signal,

wherein the electronic circuitry comprises a processor that;

analyzes the at least one cardiac signal on a beat-to-beat basis,

determines a first characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal on the beat-to-beat basis,

identifies a cardiac event based on the first characteristic of the at least one cardiac signal,

in response to identifying the cardiac event, analyzes the at least one cardiac signal within at least one predetermined sensing window, the at least one predetermined sensing window comprising a predetermined duration of time unrelated to one or more beat-to-beat durations,

determines a second characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal within the at least one predetermined sensing window, and

identifies oversensing based on the second characteristic, wherein the first characteristic comprises at least one heart rate metric and the second characteristic comprises at least one of a spectral width, a metric of signal energy content, or a heart rate metric difference.

4. A method comprising:

sensing, by a medical device, at least one cardiac signal;

analyzing, by the medical device, the at least one cardiac signal on a beat-to-beat basis;

determining, by the medical device, a first characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal on the beat-to-beat basis;

identifying, by the medical device, a cardiac event based on the first characteristic of the at least one cardiac signal;

in response to identifying the cardiac event, analyzing, by the medical device, the at least one cardiac signal within at least one predetermined sensing window, the at least one predetermined sensing window comprising a predetermined duration of time unrelated to one or more beat-to-beat durations;

determining, by the medical device, a second characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal within the at least one predetermined sensing window;

identifying, by the medical device, oversensing based on the second characteristic; and

transitioning, by the medical device, between a first state and a second state based on identifying the cardiac event.

5. The method of claim 4, wherein sensing the at least one cardiac signal comprises sensing the plurality of cardiac signals from a non-intravenous location.

6. A method comprising:

sensing, by a medical device, at least one cardiac signal;

analyzing, by the medical device, the at least one cardiac signal on a beat-to-beat basis;

determining, by the medical device, a first characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal on the beat-to-beat basis;

identifying, by the medical device, a cardiac event based on the first characteristic of the at least one cardiac signal;

in response to identifying the cardiac event, analyzing, by the medical device, the at least one cardiac signal within at least one predetermined sensing window, the at least one predetermined sensing window comprising a predetermined duration of time unrelated to one or more beat-to-beat durations;

determining, by the medical device, a second characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal within the at least one predetermined sensing window; and

identifying, by the medical device, oversensing based on the second characteristic, wherein the first characteristic comprises at least one heart rate metric and the second characteristic comprises at least one of a spectral width, a metric of signal energy content, or a heart rate metric difference.

7. A method comprising:

sensing, by a medical device, a first group of cardiac signals along a first sensing vector;

sensing, by the medical device, a second group of cardiac signals along a second sensing vector;

analyzing, by the medical device, the first and second groups of cardiac signals on a beat-to-beat basis;

determining, by the medical device, whether the first group of cardiac signals is reliable;

determining, by the medical device, whether the second group of cardiac signals is reliable;

determining, by the medical device, a first characteristic of each of the one or more of the first and second groups of cardiac signals determined to be reliable based on analyzing the cardiac signals on the beat-to-beat basis;

identifying, by the medical device, a cardiac event based on the one or more first characteristics;

in response to identifying the cardiac event, analyzing, by the medical device, at least one of the first or second groups of cardiac signals within at least one predetermined sensing window, the at least one predetermined sensing window comprising a predetermined duration of time unrelated to one or more beat-to-beat durations;

determining, by the medical device, a second characteristic of at least one of the first or second groups of cardiac signals based on analyzing the cardiac signals on the schedule based on the at least one predetermined sensing window; and

identifying, by the medical device, oversensing based on the second characteristic.

8. The method of claim 7, wherein, in response to determining that both of the first and second groups of cardiac signals are reliable, determining the second characteristic comprises:

determining a first spectral width corresponding to the first group of cardiac signals and a second spectral width corresponding to the second group of cardiac signals;

identifying at least one of the first spectral width or the second spectral width as a preferred spectral width; and

comparing the preferred spectral width to a spectral width threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on the comparison of the preferred spectral width to a spectral width threshold.

9. The method of claim 7, wherein, in response to determining that both of the first and second groups of cardiac signals are reliable, determining the second characteristic comprises:

determining a first metric of signal energy content corresponding to the first group of cardiac signals and a second metric of signal energy content corresponding to the second group of cardiac signals;

identifying at least one of the first metric of signal energy content or the second metric of signal energy content as a preferred metric of signal energy content; and

comparing the preferred metric of signal energy content to a metric of signal energy content threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on the comparison of the preferred metric of signal energy content to the metric of signal energy content threshold.

10. The method of claim 7, wherein, in response to determining that both of the first and second groups of cardiac signals are reliable, determining the second characteristic comprises:

determining a first heart rate metric difference corresponding to the first group of cardiac signals and a second heart rate metric difference corresponding to the second group of cardiac signals sensed;

identifying at least one of the first heart rate metric difference or the second heart rate metric difference as a preferred heart rate metric difference; and

comparing the preferred heart rate metric difference to a heart rate metric difference threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on the comparison of the preferred heart rate metric difference to the heart rate metric difference threshold.

11. The method of claim 7, wherein sensing a first and second group of cardiac signals comprises sensing a first and second group of cardiac signals from a non-intravenous location.

12. The method of claim 7, wherein, in response to determining that both of the first and second groups of cardiac signals are reliable, determining the second characteristic comprises:

determining a first spectral width corresponding to the first group of cardiac signals and a second spectral width corresponding to the second group of cardiac signals;

identifying at least one of the first spectral width and the second spectral width as a preferred spectral width;

comparing the preferred spectral width to a spectral width threshold;

determining a first metric of signal energy content corresponding to the first group of cardiac signals and a second metric of signal energy content corresponding to the second group of cardiac signals;

identifying at least one of the first metric of signal energy content and the second metric of signal energy content as a preferred metric of signal energy content;

comparing the preferred metric of signal energy content to a metric of signal energy content threshold;

determining a first heart rate metric difference corresponding to the first group of cardiac signals and a second heart rate metric difference corresponding to the second group of cardiac signals;

identifying at least one of the first heart rate metric difference and the second heart rate metric difference as a preferred heart rate metric difference; and

comparing the preferred heart rate metric difference to a heart rate metric difference threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on at least one of the comparison of the preferred spectral width to the spectral width threshold, the comparison of the preferred signal energy content to the signal energy content threshold, or the comparison of the preferred heart rate metric difference to the heart rate metric difference threshold.

13. The method of claim 7, further comprising controlling, by the medical device, a rate of determining the second characteristic.

14. The method of claim 7, wherein, in response to determining that the first group of cardiac signals is reliable and the second group of cardiac signals is not reliable, determining the second characteristic comprises:

determining a spectral width corresponding to the first group of cardiac signals; and

comparing the spectral width to a spectral width threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on the comparison of the spectral width to the spectral width threshold.

15. The method of claim 7, wherein, in response to determining that the first group of cardiac signals is reliable and the second group of cardiac signals is not reliable, determining the second characteristic comprises:

determining a metric of signal energy content corresponding to the first group of cardiac signals; and

comparing the metric of signal energy content to a metric of signal energy content threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on the comparison of the metric of signal energy content to the metric of signal energy content threshold.

16. The method of claim 7, wherein, in response to determining that the first group of cardiac signals is reliable and the second group of cardiac signals is not reliable, determining the second characteristic comprises:

determining a heart rate metric difference corresponding to the first group of cardiac signals; and

comparing the heart rate metric difference to a heart rate metric difference threshold, and

wherein identifying oversensing based on the second characteristic comprises identifying oversensing if the heart rate metric difference exceeds the heart rate metric difference threshold.

17. The method of claim 16, further comprising controlling, by the medical device, a rate of determining the second characteristic.

18. The method of claim 7, wherein, in response to determining that the first group of cardiac signals is reliable and the second group of cardiac signals is not reliable, determining the second characteristic comprises:

determining a spectral width corresponding to the first group of cardiac signals;

comparing the spectral width to a spectral width threshold;

determining a metric of signal energy content corresponding to the first group of cardiac signals;

comparing the metric of signal energy content to a metric of signal energy content threshold;

determining a heart rate metric difference corresponding to the first group of cardiac signals; and

comparing the heart rate metric difference to a heart rate metric difference threshold, and wherein identifying oversensing based on the second characteristic comprises identifying oversensing based on at least one of the comparison of the spectral width to the spectral width threshold, the comparison of the metric of signal energy content to the metric of signal energy content threshold, or the comparison of the heart rate metric difference to the heart rate metric difference threshold.

19. A medical device comprising:

a housing containing electronic circuitry; and

a plurality of electrodes coupled to the electronic circuitry that sense at least one cardiac signal,

wherein the electronic circuitry comprises a processor that;

analyzes the at least one cardiac signal on a beat-to-beat basis,

determines a first characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal on the beat-to-beat basis,

identifies a cardiac event based on the first characteristic of the at least one cardiac signal,

in response to identifying the cardiac event, analyzes the at least one cardiac signal within at least one predetermined sensing window, the at least one predetermined sensing window comprising a predetermined duration of time unrelated to one or more beat-to-beat durations,

determines a second characteristic of the at least one cardiac signal based on analyzing the at least one cardiac signal within the at least one predetermined sensing window, and

identifies oversensing based on the second characteristic, wherein the first characteristic comprises a heart rate characteristic and, in response to identifying oversensing based on the second characteristic, the processor determines a corrected first characteristic based on the at least one cardiac signal used to determine the first characteristic, and determines whether the cardiac event is identified based on the corrected first characteristic.